Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria La Fe (33)

2024

  1. Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue

    Biochemical Pharmacology, Vol. 223

2023

  1. Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients

    Transplantation, Vol. 107, Núm. 2, pp. 466-474

  2. Altered MicroRNA Maturation in Ischemic Hearts: Implication of Hypoxia on XPO5 and DICER1 Dysregulation and RedoximiR State

    Antioxidants, Vol. 12, Núm. 7

  3. Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients

    Transplantation, Vol. 107, Núm. 9, pp. 2064-2072

  4. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study

    Pharmaceutics, Vol. 14, Núm. 10

  2. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients

    Journal of Heart and Lung Transplantation, Vol. 41, Núm. 2, pp. 137-147

  3. Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  4. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Circulating mitochondrial genes detect acute cardiac allograft rejection: Role of the mitochondrial calcium uniporter complex

    American Journal of Transplantation, Vol. 21, Núm. 6, pp. 2056-2066

  2. Relaxin has beneficial effects on liver lipidome and metabolic enzymes

    FASEB Journal, Vol. 35, Núm. 7

2020

  1. Plasma CD5L and non-invasive diagnosis of acute heart rejection

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 3, pp. 257-266

  2. XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 13, Núm. 4, pp. 593-600

2019

  1. Circulating Sphingosine-1-Phosphate as A Non-Invasive Biomarker of Heart Transplant Rejection

    Scientific reports, Vol. 9, Núm. 1, pp. 13880

  2. Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue

    Pharmacological Research, Vol. 144, pp. 51-65

  3. The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy

    PLoS ONE, Vol. 14, Núm. 4

2018

  1. ASB1 differential methylation in ischaemic cardiomyopathy: Relationship with left ventricular performance in end-stage heart failure patients

    ESC Heart Failure, Vol. 5, Núm. 4, pp. 732-737

  2. Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis

    PLoS ONE, Vol. 13, Núm. 1

  3. Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes

    Endocrine, Vol. 60, Núm. 1, pp. 103-111

2017

  1. Changes in human Golgi apparatus reflect new left ventricular dimensions and function in dilated cardiomyopathy patients

    European Journal of Heart Failure